Heparanase activity neutralizing anti-heparanase monoclonal antibody
US6946131B2 · kind B2 · utility
3Cited by
1References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 19, 2003 |
| Grant date | Sep 20, 2005 |
| Priority date | — |
| Expiry date | Feb 19, 2023 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2400/40
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating a condition associated with heparanase expression by administering a heparanase activity neutralizing monoclonal anti-heparanase antibody, the monoclonal anti-heparanase antibody being for neutralizing heparanase catalytic activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.